Viewing Study NCT01564251


Ignite Creation Date: 2025-12-24 @ 11:52 PM
Ignite Modification Date: 2026-02-26 @ 2:15 AM
Study NCT ID: NCT01564251
Status: COMPLETED
Last Update Posted: 2020-02-25
First Post: 2012-03-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of GDC-0575 Alone and in Combination With Gemcitabine in Participants With Refractory Solid Tumors or Lymphoma
Sponsor: Genentech, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module